29 November 2019
Further to the expiry of approval of chloridazon, imazaquin and quinoclamine on 31 December 2018, ANSES withdraw 9 authorisations and 1 parallel trade permit for plant […]
12 November 2019
As a result of the entry into force of Regulation (EU) 2019/677 of 29th April 2019 concerning the non-renewal of chlorothalonil approval, ANSES withdraw 25 authorisations […]
2 September 2019
In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this evaluation, Anses has […]
16 July 2019
As a result of the entry into force of Regulation (EU) 2018/1865 of 28th November 2018 concerning the non-renewal of propiconazole approval, ANSES has withdrawn 23 […]